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Abstract
To examine effects of mother’s anxiety and depression and associated risk factors during early pregnancy on fetal growth and
activity. Repeated measures of mother’s anxiety (State-Anxiety Inventory (STAI-S)) and depression (Edinburgh Postnatal
Depression Scale (EPDS)) and related socio demographics and substance consumption were obtained at the 1st and 2nd
pregnancy trimesters, and fetus’ (N¼ 147) biometric data and behavior was recorded during ultrasound examination at 20–
22 weeks of gestation. Higher anxiety symptoms were associated to both lower fetal growth and higher fetal activity. While
lower education, primiparity, adolescent motherhood, and tobacco consumption predicted lower fetal growth, coffee intake
predicted lower fetal activity. Vulnerability of fetal development to mother’s psychological symptoms as well as to other socio-
demographic and substance consumption risk factors during early and mid pregnancy is suggested.
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Introduction
The study of human development usually considers
childbirth as the starting point. However, several
research studies have suggested that psychological
development begins during the gestational period,
and prenatal influences can explain a significant part
of the child’s behavioral and developmental varia-
bility.
Fetal growth and fetal activity have been widely
analyzed to describe normal development across
pregnancy and to identify potential risk factors. Fetal
movements have been found to reflect the integrity
and activity of the central nervous system (CNS), as
the more frequent movement patterns follow a clear
developmental course [1] and abnormal movement
patterns have been observed in fetuses with motor
disorders related to CNS development, such as
cerebral palsy [2]. With increasing gestational age,
fetal movements, eye movements and heart rate
patterns get organized into specific behavioral
states that resemble those Prechtl described in the
neonate [3].
Results of longitudinal studies involving the assess-
ment of fetal behavior in early pregnancy using 2D
sonographic scanning revealed that different move-
ments have diverse incidences and assume distinctive
patterns [4,5], as well as a decrease in overall fetal
activity from the 20 weeks of gestation until delivery
[6]. These findings are in line with new data provided
by the recent studies involving 4D sonographic
scanning [7,8].
Due to the higher sensitivity of fetal brain early in
gestation, fetuses are especially vulnerable to small
changes in the intra-uterine physiological environ-
ment, induced by internal and/or external factors.
Both animal and human studies have shown that
prenatal influences can have long lasting effects on
development and health. Maternal nutrition, for
instance, is associated with coronary heart disease
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and non-insulin dependent diabetes in adulthood,
whereas maternal depression and anxiety are
associated with problems in infant biobehavioral
development [9,10]. Hormones of the hypothala-
mic–pituitary–adrenal (HPA) axis and sex hormones
have been found to have programming effects and
were pointed out as possible explanations to such
long-term effects [11]. A number of risk factors have
been identified which may account for abnormal
growth and activity including maternal socio-demo-
graphic, substance consumption and psychological
symptoms. Considering socio-demographic risk fac-
tors, social class was clearly related to several
measures of early child morbidity and mortality
[12], and high-intensity occupational activity and
high demanding physical tasks at work have been
associated with adverse pregnancy outcomes, such as
preterm delivery [13]. Reported developmental ef-
fects of race and sex [14], parity [15–18], maternal age
[19,20], nutritional status [21–23], and maternal
anthropometrics [24–26] include the increased in-
cidence of fetal and neonatal mortality, intrauterine
growth retardation, low birth weight, premature
delivery and several neonatal morbidities, although
the direction of these effects, as well as the mutual
interplay of the risk factors awaits further elucidation.
Studies examining the association between mater-
nal substance consumption and early infant develop-
ment have mostly suggested the potential short and
long term teratogenic and neurodevelopmental con-
sequences of nicotine [27,28], caffeine [29–31], and
alcohol use during pregnancy [32], mostly when in the
presence of high doses and chronic exposure.
Reported development effects include a significant
fetal growth reduction [33–37], low birth weight and
preterm delivery [26,38,39], more time spent in a low
fetal heart rate variation pattern and decrement of fetal
activity both in high and low fetal heart rate variation
periods [40], delayed onset of response to the
maternal voice in fetuses less than 37 weeks gesta-
tional age [41] and fetal death [42]. Some animal and
human studies also revealed a combined effect of the
use of several substances by the same women, which
increases the risk of obstetric and fetal/neonatal
complications [43,44].
There is conflicting data regarding the effect of
maternal psychological distress on fetal growth and
activity. Recent empirical evidence suggests that the
nature of adverse life events [45], as well as the
moment of exposure [46,47] are important determi-
nants of these disparities. Some researchers who
found an impact of psychological distress on fetal
growth observed a growth delay in fetuses of mothers
who presented prenatal anxiety [48] and/or depres-
sion [49]; others studies only found a growth
reduction after exposure to severe life events in
premature born before 32 weeks of gestation [50].
The same effect is found for fetal activity, with fetuses
of anxious [51,52] and/or depressed [53] mothers
being more active than fetuses of non-anxious and/or
non-depressed mothers. Moreover, fetuses of anxious
mothers spend more time in passive sleep and show
more indiscriminate movements when they are in
active sleep [54,55].
Several others did not find this effect, neither for
fetal growth [56–58] nor for fetal behavior [59].
DiPietro et al. [60] suggest that mild to moderate
levels of psychological distress may enhance fetal
maturation in healthy populations, as higher levels of
prenatal anxiety, non-specific stress, and depressive
symptoms can be associated to greater motor and
mental development in children at age two.
Despite a number of prenatal influences having
been identified for infant development, the mutual
interplay of the range of such risk factors is complex
and not yet fully understood. Thus, the purpose of this
study was to explore the effects of mothers’ anxiety
and depression and associated risk factors during early
pregnancy on fetal growth and activity at 20–22 weeks
of gestation, namely by (1) examining group differ-
ences concerning mothers’ anxiety (State-Trait
Anxiety Inventory-State (STAI-S)< 45 versus
STAI-S 45) and depression (Edinburgh Postnatal
Depression Scale, EPDS< 10 versus EPDS 10) at
the 1st and 2nd trimesters across fetal growth and
movement patterns; and (2) analyzing possible effects
of mothers’ anxiety and depression at the 1st and 2nd
trimesters on fetal growth and activity at 20–22 weeks
of gestation. The effect of mothers’ socio demo-
graphics and substance consumption and fetus’
gender were also analyzed.
Methods
After approval from the Ethical Committee, partici-
pants were recruited at the antenatal Obstetric Unit
(Ju´lio Dinis Maternity Hospital, Porto, Portugal).
Medical records were consulted and all identified
women up to 14 weeks of gestation were contacted,
except those with multiple gestations and with
medical and/or obstetric complications. After in-
formed consent, which included permission for
recording fetal behavior, mother’s socio-demo-
graphics were collected. Repeated measures of
anxiety (STAI-S) and depression (EPDS) were
obtained at the 1st and 2nd pregnancy trimesters.
At the 2nd pregnancy trimester, fetus’s biometrical
data were collected from clinical reports and in a sub-
sample of 47 fetuses with gestational ages (menstrual
age) greater than or equal to 20 weeks and lower to
23 weeks, a video tape of the fetal behavior was made
by the research team’s obstetrician, during ultra-
sound examination.
Information about demographic factors, such as
age, ethnicity, nationality, employment and occu-
pation, marital status, household arrangements,
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educational attainment, medical and obstetrical
history, psychological status, and substance con-
sumption (tobacco consumption measured by num-
ber of cigarettes per day and coffee consumption
measured by number of espressos per day), was
obtained through a standardized interview.
The Spielberger [61] STAI was used to measure
anxiety symptoms. The STAI is a self-report ques-
tionnaire consisting of two subscales, the state anxiety
subscale and the trait anxiety subscale, each containing
20 items. Only the state anxiety subscale (STAI-S),
which measures anxiety at the moment of scoring, was
used in the analyses. The scores in this subscale range
from 20 to 80 and higher scores indicate higher state
anxiety (conceptualized as a transient emotional
condition of the individual, characterized by subjec-
tively experienced feelings of tension, together with a
heightened activity of the autonomous nervous sys-
tem). This scale has been used in several studies
implemented during pregnancy and the postpartum
period [62,63]. The Portuguese version of the STAI
showed good internal consistency (State and Trait
Cronbach’s a in women¼ 0.88 and 0.87, respectively)
and construct validity demonstrated by substantial
differences in scores obtained under stressful and
neutral conditions [64]. Authors suggest a cutoff of 45
for high anxiety.
The Portuguese version of the EPDS [65,66], a
self-report questionnaire composed by 10 items in a
likert scale of four points (0–3), was used to assess
depressive symptoms. Psychometric studies of the
EPDS Portuguese version showed good internal
consistency (Cronbach a¼ 0.85), test–retest reliabil-
ity (Spearman Correlation¼ 0.75), and external
validity with the Schedule for Affective Disorders
and Schizophrenia (SADS psychiatric interview)
(r¼ 0.86) [67]. A score higher than 10 indicates the
probable presence of a major depressive episode with
a sensitivity of 29% and specificity of 96% [68]. This
questionnaire has been used in several studies with
pregnant and postpartum women [63,69], some of
which in Portugal [66–68,70].
Fetal growth and activity were assessed during the
morphological ultrasound of the 2nd trimester of
pregnancy. Fetal growth measures included bipar-
ietal distance (BPD), head circumference (HC),
abdominal circumference (AC), and femur length
(FL). These measures were obtained by the obstet-
rician of the research team, using standard clinical
measurement protocols [71–73].
The spontaneous motor activity of fetuses, which
reflects the activity of the CNS [1], was video
recorded during the 2nd trimester of pregnancy
real-time ultrasound (General Electric, model Volu-
son c730 expert) following the same procedures and
fetal activity categories used in previous research
[53,74–76]. Since the nature and pattern of fetal
movements can be determined by gestational age,
mother’s feeding and circadian rhythm [77], condi-
tions for fetal movements’ assessment were standar-
dized. All fetuses had gestational ages between 20
and 22 weeks. All video recordings were performed
in the afternoon, between 2:30 p.m. and 4:00 p.m.,
with the mother in a semi supine position. Women
shouldn’t have had food intake, coffee, tea, smoking,
or alcohol consumption for 1 h and 30 min before
the recording. For the fetal movements assignment,
the obstetrician positioned the ultrasound transducer
to obtain a lateral view of the fetus, including
visualization of the head, trunk, and limbs. Taking
into account the high percentage of time in which
some of the fetuses were not accurately viewable,
leading to the repositioning of the transducer (which
induced non spontaneous fetal behavior), a max-
imum period of three consecutive minutes of good
viewing of the fetus, achieved in all participants, was
selected for fetal behavior scoring. The 3-min period
of video recording was subdivided into 3-s ‘‘win-
dows’’, in which observers should signal the occur-
rence of the following fetal activity categories
including: (a) Single limb movement (isolated arm,
leg or head movement, without movements in other
body parts); (b) Multiple limb movement (movement
which implies changes in position of the limb
segments towards each other, with limb joints being
active and moving simultaneously); and (c) Gross
body movement (movement involving the whole
body and/or limbs of the fetus lasting a variable
period of time). No movement classification should be
coded when no fetal movements occurred for a
period of 3 s. Two consecutive bursts of fetal
movements were considered as independent when a
complete absence of movements was observed
between them. For the data analyses, the percentage
of time (% time) the fetus engaged in total move-
ment, as well as in each movement category, was
calculated.
Records of five fetuses were used in the training of
three observers. Final coding of these records was
reached after the achievement agreement between
the three observers. The remaining records were
rated by two observers, with the achievement of
excellent inter-observers reliability (Kappa of Cohen
greater than or equal to 0.75) in 20 fetal assessments
and good agreement (Kappa of Cohen between 0.40
and 0.75) in 22 fetal assessments. In this case, a third
observer was used in order to obtain the final
quotation.
Multivariate analyses of variance (MANOVA)
were used to examine mothers’ 1st and 2nd
trimester’s anxiety (STAI-S< 45 versus STAI-S
 45) and depression (EPDS<10 versus EPDS
 10) group differences across the fetal growth
measures (BPD, HC, AC, and FL; dependent vari-
ables) and fetal activity categories (no movements,
single limb movement, multiple limb movement
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and gross body movement; dependent variables) at
the 2nd pregnancy trimester. Multiple regression
analyses were applied to examine the role of mothers’
1st and 2nd trimester’s anxiety (STAI-S total scores)
and depression (EPDS total scores) in the prediction
of fetal growth measures and activity categories,
respectively, at the 2nd trimester of pregnancy. Data
were analyzed using the Statistical Package for the
Social Sciences (SPSS), version 15.0.
Results
The sample involved 147 fetuses (49% females and
51% males) with gestational ages of 20 (44.9%), 21
(34.7%), and 22 (20.4%) weeks (M¼ 21.05;
SD¼ 0.77). The mean of each biometric parameter
(BPD, HC, AC, and FL) was within the normative
range of values expected for the same menstrual age.
Information on fetal outcome is available for 130
fetuses (88.4%). Most of these infants were born
after a normal (86.2%) full-term gestation (96.9%;
M¼ 38.91, SD¼ 1.27, Min¼ 35.00, Max¼ 42.00),
not needing reanimation procedures (94.6%). More
than half of the deliveries were dystocic (51.5%;
40.8% with cesarean section and 10.7% deliveries by
forceps/ventouse), and used anesthetic procedures
(90.0%). At time of birth, newborns’ HC s ranged
between 24.0 and 45.5 cm (M¼ 34.66, SD¼ 2.66),
most of them (93.1%) had birth weight equal or
higher than 2500 g (M¼ 3191.72, SD¼ 462.04,
Min¼ 1830.00, Max¼ 4415.00), birth length equal
or higher than 47 cm (83.8%; M¼ 48.70, SD¼ 2.21,
Min¼ 42.00, Max¼ 55.50), Ponderal index equal or
higher than 2.50 (82.3%; M¼ 2.75, SD¼ 0.26,
Min¼ 2.15, Max¼ 3.79), and Apgar Index equal or
higher to 7 at the 1st (92.9%) and 5th (99.2%)
minute.
Mothers were primı´parous (53.7%) and multı´-
parous (46.3%), Portuguese (88.4%), and Caucasian
(93.2%). Most mothers (89.1%) were older than 19
(M¼ 27.04, SD¼ 5.90; Min¼ 15; Max¼ 41), had
completed high school (9–12 years of study) and
were employed. A large percentage of women lived
with their partners (86.4%), and the household
included other elements from the extended family
in 23.8% of cases. From the 147 mothers-to-be, 19
(12.9%) reported tobacco use (14 women with
 3\<10 cigarettes/day and 5 women¼ 10 cigar-
ettes/day; M¼ 2.42, SD¼ 6.79; Min¼ 3; Max¼ 10
cigarettes per day) and 39 (26.5%) espresso coffee
intake (37 women with 1 or 2 espressos/day and
2 women with 3 or 4 espressos/day (Min¼ 1
(+75 mg) 7 Max¼ 4 (+300 mg) cups of coffee
per day), but none reported alcohol or drug
consumption during pregnancy (cf. Table I).
Multivariate analyses of variance (MANOVA)
were used to examine mothers’ 1st and 2nd tri-
mester’s anxiety (STAI-S< 45 versus STAI-S  45)
and depression (EPDS< 10 versus EPDS 10)
group differences across the fetal growth measures
(BPD, HC, AC, and FL; dependent variables). No
significant group differences were found across the
independent variables of anxiety (STAI-S) at the 1st
trimester (Wilks’ l¼ 0.977; F(4, 142)¼ 0.834;
p¼ 0.506), depression (EPDS) at the 1st trimester
(Wilks’ l¼ 0.981; F(4, 142)¼ 0.693; p¼ 0.598),
anxiety (STAI-S) at the 2nd trimester (Wilks’
l¼ 0.984; F(4, 142)¼ 0.594; p¼ 0.668) and depres-
sion (EPDS) at the 2nd trimester (Wilks’ l¼ 0.980;
F(4, 142)¼ 0.716; p¼ 0.582).
Different forced entry multiple regression analyses
were performed to identify mother and fetus socio-
demographics and substance consumption potential
predictors (p< 0.150) of each fetal growth measure
(BPD, HC, AC, and FL) at the 2nd pregnancy
trimester.
Parity appeared as a potential socio-demographic
predictor of BPD (b¼ 0.171; p¼ 0.054), HC
(b¼ 0.228; p¼ 0.009), AC (b¼ 0.150; p¼ 0.083)
and FL (b¼ 0.210; p¼ 0.017). Education and
maternal age appeared as potential socio-demo-
graphic predictors of HC (b¼ 0.134; p¼ 0.117) and
AC (b¼ 0.231; p¼ 0.027), respectively. Mother’s
smoking during pregnancy emerged as a potential
substance consumption predictor of BPD (b¼ 0.194;
p¼ 0.021).
In a final hierarchical regression analysis (block-
wise entry), each fetal growth measure (depen-
dent variable) was regressed on mothers’ anxiety
(STAI-S total scores) and depression (EPDS total
scores) at the 1st and 2nd trimesters (Block 1),
followed by previously identified socio-demographic
and substance consumption potential predictors
(Block 2).
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As shown in Table II, mothers’ anxiety (STAI-S
total scores) and depression (EPDS total scores) at
the 1st and 2nd trimesters (Block 1) did not
significantly predict or explain the variance of fetal
growth measures, with the exception of FL (BPD,
F(4, 141)¼ 0.947, p¼ 0.439; HC, F(4, 141)¼ 1.046,
p¼ 0.386; AC, F(4, 142)¼ 1.154, p¼ 0.334).
When tobacco consumption and parity variables
were added to the final regression model of BPD
(Block 2), 8.6% of the variance in this dependent
variable was explained, DR2¼ 0.060, DF(2, 139)¼
4.564, p¼ 0.012, with tobacco consumption
emerging as a significant predictor and STAI-S and
EPDS at both trimesters and parity not contributing
significantly. Mother’s smoking during pregnancy
significantly predicted higher fetus’ BPD (cf.
Table II).
When education and parity were added to the final
regression model of HC (Block 2), 12% of the
variance in this dependent variable was explained,
DR2¼ 0.091, DF(2, 139)¼ 7.217, p¼ 0.001, with
STAI-S at the 2nd trimester, education and parity
significantly predicting HC, while STAI-S at the 1st
trimester and EPDS at both trimesters did not
Table II. Predictors of fetal growth at 20–22 weeks: multiple hierarchical regression (final model), Blockwise entry (N¼147).
Dependent variables Independent variables R2 DR2 F b t
BPD Step 1
STAI-S 2nd trim 70.249 71.893
EPDS 2nd trim 0.111 0.856
STAI-S 1st trim 0.149 1.094
EPDS 1st trim 0.026 – 0.947 70.002 70.018
Step 2
STAI-S 2nd trim 70.247 71.921
EPDS 2nd trim 0.060 0.474
STAI-S 1st trim 0.156 1.173
EPDS 1st trim 0.003 0.019
Tobacco use 0.168 2.048*
Parity 0.086 0.060 2.184* 0.163 1.952
HC Step 1
STAI-S 2nd trim 70.255 71.939
EPDS 2nd trim 0.029 – 1.046 0.058 0.449
STAI-S 1st trim 0.159 1.170
EPDS 1st trim 0.032 0.238
Step 2
STAI-S 2nd trim 70.306 72.410*
EPDS 2nd trim 0.017 0.139
STAI-S 1st trim 0.168 1.288
EPDS 1st trim 0.067 0.506
Education 0.212 2.557*
Parity 0.120 0.091 3.165** 0.276 3.312**
AC Step 1
STAI-S 2nd trim 70.172 71.313
EPDS 2nd trim 70.005 70.037
STAI-S 1st trim 0.166 1.221
EPDS 1st trim 0.031 – 1.154 0.106 0.789
Step 2
STAI-S 2nd trim 70.202 71.585
EPDS 2nd trim 70.012 70.097
STAI-S 1st trim 0.146 1.107
EPDS 1st trim 0.126 0.962
Maternal age 0.222 2.685**
Parity 0.101 0.070 2.621* 0.111 1.331
FL Step 1
STAI-S 2nd trim 70.324 72.501*
EPDS 2nd trim 0.192 1.509
STAI-S 1st trim 0.217 1.616
EPDS 1st trim 0.048 – 1.777 70.045 70.334
Step 2
STAI-S 2nd trim 70.336 72.633**
EPDS 2nd trim 0.155 1.235
STAI-S 1st trim 0.230 1.736
EPDS 1st trim 70.050 70.381
Parity 0.085 0.038 2.632* 0.199 2.411*
**p< 0.01; *p< 0.05.
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contribute significantly. High mother’s anxiety at the
2nd trimester, lower education and primiparity
significantly predicted lower fetus’ HC (cf. Table II).
When maternal age and parity were added to the
final regression model of AC (Block 2), 10.1% of the
variance in this dependent variable was explained,
DR2¼ 0.070, DF(2, 140)¼ 5.412, p¼ 0.005, with
maternal age emerging as a significant predictor of
AC, while STAI-S and EPDS at both trimesters and
parity did not contribute significantly: lower maternal
age (adolescent motherhood) significantly predicted
lower fetus’s AC (cf. Table II).
In the final hierarchical regression analysis (block-
wise entry) of FL, the model with mother’s anxiety
(STAI-S total scores) and depression (EPDS total
scores) at the 1st and 2nd trimesters (Block 1) was
not significant, although STAI-S at the 2nd preg-
nancy trimester emerged as a significant predictor,
F(4, 142)¼ 1.77, p¼ 0.137. When parity was
added to the model, 8.5% of the variance in FL
was explained, DR2¼ 0.038; DF(1, 141)¼ 5.812,
p¼ 0.017, with STAI-S at the 2nd trimester and
parity as significant predictors, while STAI-S at the
1st trimester and EPDS at either trimester did not
contribute significantly. High mother’s anxiety at the
2nd trimester and primiparity significantly predicted
lower fetus’s FL (cf. Table II).
As can be seen in Table III in this sample the
presence and absence of fetal movements occupied,
on average, the same percentages of the time, and
during the active periods, Gross body movement was
the most prevalent category of fetal activity.
Multivariate analyses of variance (MANOVA)
were used to examine mother’s 1st and 2nd tri-
mester’s anxiety (STAI-S< 45 versus STAI-S 45)
and depression (EPDS< 10 versus EPDS 10) group
differences across the fetal activity categories (No
movement, Single limb movement, Multiple limb
movement, and Gross body movement) No signifi-
cant group differences were found across the
independent variables of anxiety (STAI-S) (Wilks’
l¼ 0.898; F(4, 42)¼ 1.187; p¼ 0.330) and depres-
sion (EPDS) (Wilks’ l¼ 0.974; F(4, 42)¼ 0.275;
p¼ 0.892) at the 1st trimester.
MANOVA multivariate tests did not show sig-
nificant group differences across any fetal activity
categories taking into account the independent
variable depression (EPDS) at the 2nd pregnancy
trimester (Wilks’ l¼ 0.844; F(4, 42)¼ 1.942;
p¼ 0.121), but MANOVA univariate tests showed
that fetuses of depressed mothers spent significantly
more time in Single limb movements at the 2nd
pregnancy trimester than fetuses of non-depressed
mothers at the time (cf. Table IV).
Significant group differences were found across
the fetal activity categories taking into account the
independent variable of anxiety (STAI-S) at the 2nd
trimester of pregnancy (Wilks’ l¼ 0.788; F(4, 42)¼
2.831; p¼ 0.036): fetuses of anxious mothers spent
significantly more time in Single limb movements at
the 2nd pregnancy trimester than fetuses of non-
anxious mothers at the time (cf. Table IV).
As for fetal growth measures, different forced entry
multiple regression analyses were performed to
identify mothers’ and fetus’s socio-demographics
and substance consumption potential predictors
(p< 0.150) for each fetal activity category (no move-
ments, single limb movement, multiple limb move-
ment and gross body movement) at the 2nd
pregnancy trimester.
Table III. Fetal activity at 20–22 weeks (N¼ 47).
Min–Max Mean (DP) 25th–75th Percentile
No movement (% time) 1.70–98.30 54.20 (25.17) 33.30–75.00
Single limb movement (% time) 0.00–30.00 8.96 (7.85) 3.30–15.00
Multiple limb movement (% time) 0.00–16.70 3.39 (4.38) 0.00–6.65
Gross body movement (% time) 1.70–96.70 33.45 (22.85) 13.30–45.00
Table IV. Mother’s anxiety and depression (2nd trimester of pregnancy): MANOVA for fetal activity categories at 20–22 weeks (N¼ 47).
N
No movement Single limb movement
Multiple limb
movement Gross body movement
Mean (SD) F(1,45) Mean (SD) F(1,45) Mean (SD) F(1,45) Mean (SD) F(1,45)
STAI-S
<45 35 52.84 (25.92) 0.397 7.62 (6.34) 4.257* 2.86 (3.66) 2.053 36.68 (23.57) 2.847
45 12 58.18 (23.43) 12.85 (10.53) 4.94 (5.97) 24.03 (18.34)
EPDS
<10 35 54.98 (25.04) 0.130 7.43 (6.32) 5.730* 2.74 (3.60) 3.144 34.85 (23.70) 0.506
10 12 51.92 (26.52) 13.41 (10.25) 5.29 (5.94) 29.38 (20.55)
*p< 0.05.
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Mothers’ coffee intake during pregnancy emerged
as a potential substance consumption predictor of
time spent by the fetus in Single limb movements
(b¼70.334; p¼ 0.024) and Multiple limb move-
ments (b¼70.253; p¼ 0.095). No socio-demo-
graphics and substance consumption potential
predictors were found to the remaining fetal activity
categories.
In a final hierarchical regression analysis (block-
wise entry), each fetal activity category (dependent
variable) was regressed on mother’s anxiety
(STAI-S total scores) and depression (EPDS total
scores) at the 1st and 2nd trimester (Block 1),
followed by previously identified socio-demographic
and substances consumption potential predictors
(Block 2).
As can be seen in Table V, mother’s anxiety
(STAI-S total scores) and depression (EPDS total
scores) at the 1st and 2nd trimester (Block 1) didn’t
significantly predict or explain the variance observed
in the time spent in any of the fetal activity categories,
except for Multiple limb movement (No movement,
F(4, 42)¼ 0.855, p¼ 0.499; Single movements,
F(4, 42)¼ 1.681, p¼ 0.172; Gross body movements,
F(4, 42)¼ 1.556, p¼ 0.204).
When coffee intake was added to the final reg-
ression model of single limb movement, 25.5% of the
variance was explained, DR2¼ 0.117, DF(1, 41)¼
6.420, p¼ 0.015, with coffee intake predicting
significantly less time spent in Single limb move-
ments while STAI-S and EPDS at both trimesters
did not contribute significantly (cf. Table V).
Although STAI-S at the 1st trimester emerged as a
significant predictor of multiple limb movement, the
model with mother’s anxiety (STAI-S total scores)
and depression (EPDS total scores) at the 1st and
2nd trimesters (Block 1) was not significant,
F(4, 42)¼ 1.623, p¼ 0.186. The addition of coffee
intake to the model did not contribute significantly to
predict multiple limb movement, DR2¼ 0.073;
DF(1, 41)¼ 3.766, p¼ 0.059, even though STAI-S
at the 1st trimester remained a significant predictor.
Higher mother’s anxiety at the 1st trimester sig-
nificantly predicted more time spent in Multiple limb
movements (cf. Table V).
Discussion
The focus of the present study was to examine the
effects of mothers’ anxiety and depression and
Table V. Predictors of fetal activity categories at 20–22 weeks: multiple hierarchical regression (final model), Blockwise entry (N¼ 47).
Dependent variables Independent variables R2 DR2 F b t
No movement Step 1
STAI-S 2nd trim 0.214 0.729
EPDS 2nd trim 70.282 71.064
STAI-S 1st trim 0.172 0.659
EPDS 1st trim 0.075 – 0.855 70.193 70.804
Single limb movement Step 1
STAI-S 2nd trim 0.062 0.219
EPDS 2nd trim 0.010 0.039
STAI-S 1st trim 0.318 1.267
EPDS 1st trim 0.138 – 1.681 70.006 70.026
Step 2
STAI-S 2nd trim 0.007 0.024
EPDS 2nd trim 0.015 0.062
STAI-S 1st trim 0.341 1.442
EPDS 1st trim 0.010 0.044
Coffee intake 0.255 0.117 2.802* 70.343 72.534*
Multiple limb movement Step 1
STAI-S 2nd trim 70.459 71.618
EPDS 2nd trim 0.280 1.089
STAI-S 1st trim 0.566 2.246*
EPDS 1st trim 0.134 – 1.623 70.166 70.712
Step 2
STAI-S 2nd trim 70.503 71.824
EPDS 2nd trim 0.283 1.140
STAI-S 1st trim 0.584 2.391*
EPDS 1st trim 70.153 70.679
Coffee intake 0.207 0.073 2.137 70.271 71.941
Gross body movement Step 1
STAI-S 2nd trim 70.168 70.592
EPDS 2nd trim 0.129 – 1.556 0.253 0.984
STAI-S 1st trim 70.407 71.611
EPDS 1st trim 0.247 1.057
*p< 0.05.
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associated risk factors during early pregnancy on fetal
growth and activity at 20–22 weeks. In line with
previous epidemiological studies, present results also
observed the vulnerability of fetal development to
mother’s psychological symptoms, as well as to other
socio-demographic and substance consumption risk
factors during early and mid pregnancy. In addition,
current analyses made new contributions to the study
of prenatal determinants of fetal development. First,
present findings associate higher anxiety symptoms,
more than depression symptoms, to both lower fetal
growth and higher fetal activity, although more
significant for fetal behavior. Second, a differential
impact of each risk factor on fetal growth and activity
was pointed out. While lower education, primiparity,
adolescent motherhood, and tobacco consumption
predicted lower fetal growth, coffee intake predicted
lower fetal activity. Finally, the mutual interplay of
the range of risk factors shows its relevance in the
understanding of the course of early infant develop-
ment.
A lack of support was found for the independent
effect of mothers’ anxiety and depression early in
pregnancy on fetal growth measures at 20–22 weeks
of gestation, except for femur length (affected by
mothers’ anxiety at the 2nd trimester of pregnancy).
These findings are consistent with previous studies
which also suggest subtle disruptions in normative
development provoked by maternal psychological
symptoms [56–58]. Even so, when the effects of
mothers’ socio-demographic and substance con-
sumption risk factors was explored in association to
psychological symptoms, maternal education, age,
parity, tobacco consumption during pregnancy and
anxiety symptoms at the 2nd trimester appeared as
significant predictors of fetal growth, suggesting the
relevance of the mutual interplay of the range of
antenatal risk factors in determination of fetal
development [78].
Reported developmental effects of lower educa-
tion, such as preterm delivery, have already been
referred by other studies focused on prenatal
determinants of neonatal outcomes [78]. Although
several mechanisms were proposed to explain the
way socio-demographic factors, such as education,
can operate, namely by the observed correlation of
these factors with adverse life events [79], more
clinical research is needed to further understand the
causal pathways, specifically related to the impact on
fetal growth.
Primiparity was associated in the present study to
lower fetal growth. Similarly, primiparity has been
previously identified as an independent risk factor for
intrauterine growth retardation [17], small-for-gesta-
tional-age [18], or birth weight [17,80]. There is still
an ongoing debate regarding the possible underlying
mechanisms by which parity affects early human
development [for a revision see 15,16].
The same debate exists when the developmental
effects of maternal age are analyzed. Young maternal
age (adolescent motherhood) was associated in the
present study to lower fetal growth, as observed in
previous researches for obstetric [19,20] and neona-
tal outcomes [21–23]. Maternal nutrition, associated
not only to inadequate or marginal nutritional status
during pregnancy, but also to the hierarchy of
nutrient partitioning in order to promote simulta-
neously for fetal growth and the growth of the
maternal body [21–23], poor socio-economic status
and gynecological immaturity [81], and maternal
somatic features and anthropometrics [24–26] are
some of the factors pointed out as possible mediators
of this effect [for a deeply knowledge of the debate
around the mediation role of these different aspects
see 25].
As mentioned previously, an effect of tobacco
consumption on fetal growth was found in the
present study. Fetuses of mothers who smoked
during pregnancy had higher BPDs than those of
non-smoking mothers. Despite the small number of
women in this sample who reported tobacco con-
sumption, this result it is consistent with previous
findings of Lampl et al. [82], who observed that
smoke exposure was significantly associated with
early growth acceleration in head and abdominal
diameters at 20–27 weeks, followed by altered head
shape (a significantly smaller biparietal to occipital
frontal diameter ratio at 32 weeks), and a proximal/
distal growth gradient as proportionately long arms
(at 27 and 32 weeks) and short legs were apparent by
32 weeks, with a significant reduction in the tibia/
femur ratio. According to these researchers, the
greater early gestational upper body growth with
preferential growth of head dimensions, upper limb
length, and abdominal size with smoke exposure may
reflect an upregulation of normal cellular growth
mechanisms, which can be a sign of an evolutionary
adaptive response strategy. This strategy would
function under conditions of energy restriction, such
as those involved in fetal smoke exposure during
gestation, to preserve fetal development. Through
selective growth restriction and augmentation the
fetus is capable of adjusting its own growth to match
available resources. However, as Lampl et al. [82]
alert, these adaptive strategies may not be entirely
beneficial in the long term, as there may be side
effects of the upregulated cellular functions, which
can cause abnormal, compensatory growth of struc-
tures. Compensatory growth changes the normal
biological design of developing organs and an altered
cellular histology, which leaves the organism at risk
for subsequent functional sequels. This hypothesis
was also sustained by the results of Jaddoe et al. [27]
who found, in a population-based prospective cohort
study, associations between maternal smoking during
pregnancy, mainly from late pregnancy onwards, and
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impaired growth in fetal HC and AC. As the present
study did not focus fetal development near the end of
gestation, we cannot assess the validity of this
hypothesis, although preliminary non-published re-
sults obtained with the same sample, associate lower
birth weight in newborns of mothers who smoked
during pregnancy. Further investigation in this
domain, namely in the effect of prenatal anxiety
and depression early in gestation in these growth
patterns is, thus, recommended.
An association between mothers’ anxiety and
depression and higher fetal activity was observed in
the present study, similarly to what previous
researches aimed to analyze the effect of maternal
psychological symptoms on fetal behavior have
found. For instance, Dieter et al. [53] also showed
that fetuses of depressed mothers were more active
than those of non-depressed mothers at the 5th, 6th,
and 7th months of pregnancy. DiPietro et al. [51]
verified, in a sample of 52 mothers and fetuses,
assessed at 24, 30, and 36 weeks of gestation, that the
fetuses of more emotional women, assessing their
lives as more stressful and signalizing more difficul-
ties during pregnancy, were more active, than those
of mothers who perceived their pregnancy with
positive emotionality. Mediation mechanisms invol-
ving stress hormones, the HPA axis and role of the
placenta have been proposed to explain the associa-
tion between maternal psychological symptoms and
fetal behavior [83,84].
Although there is a growing awareness that
quantitative assessment of fetal activity seems to be
more valuable to demonstrate trends in the variance
of activity than for identifying individual fetuses at
high risk [85], it is also true that the inhibition is a
hallmark of neurological development and, conse-
quently, a decrement in fetal activity should be found
during gestation [86,87]. In the same way, a gradual
increment in coordination of motor activity is
expected [88], as both aspects are signs of central
nervous development [1]. Due to that, and despite
the fact some cautions should be taken when general
conclusions are proposed, higher fetal activity,
especially of less coordinate single limb movements,
found in fetus of anxious/depressed mothers when
compared to non-anxious/non-depressed mothers,
can be taken as a sign of higher immaturity of the
nervous system in these fetuses.
Espresso is one of the most popular beverages in
Portugal, being widely consumed. Almost a quarter
of the pregnant women of the sample reported
espresso consumption. Thus, the understanding of
the mutual interplay of the range of risk factors in the
determination of early infant development, proposed
as one of the major aims/contributions of the present
study, requires the analysis of the effect of coffee
intake on fetal growth and activity. An effect of
mothers’ coffee intake during pregnancy on fetal
activity was found, with fewer single movements
being observed in fetuses whose mothers consumed
coffee during gestation, when compared to mothers
without this consumption. Although evaluation of
the human developmental risks of caffeine is difficult
and findings are inconsistent, as already suggested in
previous reports, it is also true that the medical
literature contains many distinct references that
appear to indicate that human adverse reproductive/
developmental effects are produced by caffeine [29].
The fact that many caffeine users are subject to
multiple confounding factors and, the considerable
variation in caffeine content of foods and beverages,
may interfere with the attainment of valid interpreta-
tions [29]. Even so, according to a few epidemiolo-
gical studies it is assumed that one espresso contains
70–80 mg of caffeine, which was sufficient, accord-
ing to some studies, to explain several reported
effects in fetal development [for a revision see 29,89].
The mechanisms through which this impact can be
observed may include the acknowledged association
between coffee intake and the consumption of other
substances, such as alcohol and tobacco [29,90].
The major limitations of the present study were
related to the small size of the sub-sample involved in
the assessment of fetal behavior and to the small
period of 3 min for observation of motor activity,
when compared to previous studies developed in this
domain [59,91]. These limitations resulted from
institutional constraints to the implementation of the
present research which imposed the assessment of
fetal movements by the obstetrician during the
morphological ultrasound routine. Due to that a
maximum period of 10 min was allowed by the
maternity hospital for video recording of fetal
activity. The exclusive interest in fetal spontaneous’
behavior established the use of a period maximum of
3 consecutive minutes of good viewing of the fetus,
achieved by all participants, for fetal behavior
scoring, taking into account the high percentage of
time in which some of the fetuses were not accurately
viewable (which, in turn, determined the need for
repositioning of the transducer). Even so, the similar
distribution of the presence and absence of the
different fetal movement patterns, when compared
with results of previous studies, which aimed at the
quantitative aspects of fetal motor activity [5,86],
suggest that the 3 min observation can be considered
as representative of fetal behavior in mid gestation,
even though some critics can be addressed to the
assessment of fetal behavior, in consequence of the
evolution of ultrasound machines.
Despite these limitations, the current findings
support previous research indicating a detrimental
effect of maternal psychological distress during
pregnancy on fetal development. Mainly when
different risk factors, such as mothers’ psychopatho-
logical symptoms, sociodemographic disadvantage
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and substance consumption are combined. The
investigation of the impact of both anxiety and
depression symptoms on fetal growth and behavior,
and the deep understanding of the mutual interplay
of the range of risk factors in the determination of
early infant development appear, in this way, the
major contributions of the present study. The results
of the current research also suggest the differential
impact that these diverse risk factors can have on fetal
growth and activity and the importance of the
moment of exposure in determining the course of
this impact. Interdisciplinary interventions, which
should begin early in gestation and take into account
the bio psychosocial reality of the families, were
recommended. The examination of present findings
in larger samples, namely taking into account
the multiple relationships that can exist between
different risk factors, is advised, in that the deep
knowledge of the pathway by which each prenatal
factor affects child development will allow health
professionals to establish more efficient preventive
interventions.
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What this study adds
. Support for the previous findings suggesting the vulnerability of fetal development to maternal
psychological distress (anxiety and depression) during pregnancy, mainly when associated with other
risk factors such as socio-demographic disadvantage, tobacco use and coffee intake.
. The differential impact of the diverse risk factors on fetal growth and activity.
. The importance of the moment of exposure in determination of the course of this impact.
Current knowledge on this subject
. Psychological development begins during the gestational period, and prenatal influences can explain a
significant part of the child’s future behavioral and developmental variability.
. Psychosocial distress, socio-demographic disadvantage, and substance consumption have been
suggested as risk factors of fetal development.
. Non consensual results related to the effects of maternal anxiety and depression during pregnancy on
fetal growth and activity was obtained.
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